Free Newsletter
Adult stem cell therapy begins human trial
For the first time in humans a doctor has extracted adult stem cells from fat tissue and injected them directly into the heart as a therapy for angina and heart disease. Physicians in Spain--working with investigators at the Texas Heart Institute in Houston--say that it will be at least six months before they can determine if the therapy is working. Another 35 volunteers suffering from chronic myocardial ischemia, a severe form of end-stage coronary artery disease, will be given the therapy developed by Cytori Therapeutics. In preclinical tests the therapy spurred improved circulation in the heart.
"Patients with chronic heart disease today have few options making this an important milestone for the affected patients and doctors that treat them," said Marc H. Hedrick, M.D., president for Cytori Therapeutics. "This study is designed to show unequivocally whether the cells from our Celution System can be safely introduced into the heart."
- see the release on the trial
Related Articles:
New study to use stem cells after heart attacks. Report
Heart muscle created from embryonic stem cells. Report
Scientists grow new heart valves from stem cells. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: